Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Rainbird
    Member
    • Dec 2012
    • 16

    #1

    Zero fpkm estimation using cuffquant/cuffnorm (Cufflinks 2.2.1)

    Hi,

    I'm running pre-compiled cuffquant/cuffnorm from cufflinks 2.2.1 on two workstations. Both have tophat-2.0.9, samtools-0.1.19 and bowtie2-2.1.0 installed and specified in $PATH.

    The cuffquant/cuffnorm pipeline works just fine on the workstation running CentOS 6.4. However, the other one, which runs CentOS 7, has some problem of estimating normalized expression value. Specifically, it outputs 0 value for every transcripts for some RNA-seq sequencing data.

    For the data with error, I tried to move the abundances.cxb file generated by cuffquant from the CentOS 7 workstation to the CentOS 6.4 workstation, and then used the cuffnorm on CentOS 6.4 workstation to re-estimate the normalized expression value, but no luck. However, if I tracked back one more step and moved the accepted_hits.bam from CentOS 7 workstation to the CentOS 6.4 workstation, and did the rest cuffquant/cuffnorm steps on the CentOS 6.4 workstation, it will give out reasonable values. It seems to me that the problem comes from the cuffquant step, but I can't figure it out why.

    Any one could help?
    Thanks a lot,
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Consider upgrading the tuxedo suite programs to latest versions (unless you have some specific reason not to). You are using versions that were current as of Mid-2013 which is old is NGS life-cycle terms.

    Comment

    • Rainbird
      Member
      • Dec 2012
      • 16

      #3
      It seems that the cuffquant/cuffnorm steps are not included in tuxedo yet.
      The good thing about the cuffquant/cuffnorm is that I can do addtional tests based on the normalized expression values.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      40 views
      0 reactions
      Last Post SEQadmin2  
      Working...